Study of Ixekizumab in Healthy Participants
Clinical trial NCT03848403 · TERMINATED
Trial details
- NCT number
- NCT03848403
- Sponsor
- Eli Lilly and Company
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-29
- Primary completion
- 2019-07-18
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.